Advisory Research
PIIIW icon

Advisory Research’s P3 Health Partners Inc Warrant PIIIW Stock Holding History

Advisory Research’s Portfolio PIIIW Stock Details PIIIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-65,835
Closed -$5.27K – 475
2023
Q1 		$5.27K Hold
65,835
– – ﹤0.01% 345
2022
Q4 		$9.22K Hold
65,835
– – ﹤0.01% 357
2022
Q3 		$49K Sell
65,835
-1,517
-2% -$1.09K ﹤0.01% 329
2022
Q2 		$34K Sell
67,352
-30,348
-31% -$35.8K ﹤0.01% 329
2022
Q1 		$155K Hold
97,700
– – 0.01% 347
2021
Q4 		$103K Buy
+97,700
New +$118K 0.01% 317

Other funds holding PIIIW

LMR Partners
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Highbridge Capital Management
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
AC
Athos Capital Hong Kong $282M AUM 11.4% 1-Year Est. Return
EMFO LLC
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
PEAK6 Investments
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
Moore Capital Management
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
Tenor Capital Management
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Advisory Research's PIIIW Position: Q2 2023 in Review

Advisory Research sold out of P3 Health Partners Inc Warrant (PIIIW) in Q2 2023, closing a stake of 65,835 shares — an estimated $5.27K sold.

Advisory Research first reported a position in PIIIW in Q4 2021 and held it in 6 quarters. The position peaked at $155K in Q1 2022. 22 funds tracked by Wall St. Rank hold PIIIW as of Q2 2023.

  • Advisory Research reported no remaining P3 Health Partners Inc Warrant position as of Q2 2023 after selling out during the quarter.
  • Advisory Research sold 65,835 P3 Health Partners Inc Warrant shares in Q2 2023, an estimated $5.27K.
  • Advisory Research first reported a position in P3 Health Partners Inc Warrant in Q4 2021 and held it in 6 quarters.
  • Advisory Research's P3 Health Partners Inc Warrant position peaked at $155K in Q1 2022.
  • 22 funds tracked by Wall St. Rank held P3 Health Partners Inc Warrant as of Q2 2023.

Based on Advisory Research's 13F filing for Q2 2023, filed 14 Aug 2023.